Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01905592
Title A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)
Acronym BRAVO
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | ISR | ISL | HUN | GRC | GBR | FRA | ESP | CAN | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site Los Angeles California 90033 United States Details
GSK Investigational Site Los Angeles California 90048 United States Details
GSK Investigational Site Fort Myers Florida 33901 United States Details
GSK Investigational Site Miami Florida 33176 United States Details
GSK Investigational Site Boston Massachusetts 02111 United States Details
GSK Investigational Site Omaha Nebraska 68114 United States Details
GSK Investigational Site Henderson Nevada 89074 United States Details
GSK Investigational Site Clifton Park New York 12065 United States Details
GSK Investigational Site Lake Success New York 11042 United States Details
GSK Investigational Site Cleveland Ohio 44195 United States Details
GSK Investigational Site Eugene Oregon 97401 United States Details
GSK Investigational Site Portland Oregon 97225 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Nashville Tennessee 37232 United States Details
GSK Investigational Site Dallas Texas 75237 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site San Antonio Texas 78217 United States Details
GSK Investigational Site Webster Texas 77598 United States Details
GSK Investigational Site Weslaco Texas 78596 United States Details
GSK Investigational Site Low Moor Virginia 24457 United States Details
GSK Investigational Site Everett Washington 98201 United States Details
GSK Investigational Site Seattle Washington 98111 United States Details
GSK Investigational Site Green Bay Wisconsin 54311 United States Details
GSK Investigational Site Aalst 9300 Belgium Details
GSK Investigational Site Brussels 1200 Belgium Details
GSK Investigational Site Bruxelles 1000 Belgium Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Liège 4000 Belgium Details
GSK Investigational Site Namur 5000 Belgium Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Kelowna British Columbia V1Y 5L3 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H2L 4M1 Canada Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Dijon Cedex 21079 France Details
GSK Investigational Site Lille Cedex 59020 France Details
GSK Investigational Site Lyon Cedex 08 69373 France Details
GSK Investigational Site Montpellier 34298 France Details
GSK Investigational Site Nantes cedex 44202 France Details
GSK Investigational Site Paris Cedex 5 75248 France Details
GSK Investigational Site Saint-Cloud 92210 France Details
GSK Investigational Site Heraklion,Crete 71110 Greece Details
GSK Investigational Site Maroussi 15123 Greece Details
GSK Investigational Site Nea Kifissia 14564 Greece Details
GSK Investigational Site Neo Faliro 18547 Greece Details
GSK Investigational Site Thessaloniki 57001 Greece Details
GSK Investigational Site Budapest 1122 Hungary Details
GSK Investigational Site Debrecen 4032 Hungary Details
GSK Investigational Site Miskolc 3501 Hungary Details
GSK Investigational Site Nyiregyhaza 4400 Hungary Details
GSK Investigational Site Pécs 7624 Hungary Details
GSK Investigational Site Szeged 6720 Hungary Details
GSK Investigational Site Reykjavik IS-101 Iceland Details
GSK Investigational Site Haifa 3109601 Israel Details
GSK Investigational Site Holon 58100 Israel Details
GSK Investigational Site Kfar-Saba 44281 Israel Details
GSK Investigational Site Rehovot 76100 Israel Details
GSK Investigational Site Tel Aviv 6423906 Israel Details
GSK Investigational Site Tel Hashomer 52621 Israel Details
GSK Investigational Site Meldola (FC) Emilia-Romagna 47014 Italy Details
GSK Investigational Site Parma Emilia-Romagna 43100 Italy Details
GSK Investigational Site Rimini Emilia-Romagna 47900 Italy Details
GSK Investigational Site Viterbo Lazio 01100 Italy Details
GSK Investigational Site Genova Liguria 16132 Italy Details
GSK Investigational Site Cremona Lombardia 26100 Italy Details
GSK Investigational Site Milano Lombardia 20141 Italy Details
GSK Investigational Site Ancona Marche 60020 Italy Details
GSK Investigational Site Lecce Puglia 73100 Italy Details
GSK Investigational Site Prato Toscana 59100 Italy Details
GSK Investigational Site Legnago (VR) Veneto 37045 Italy Details
GSK Investigational Site Leiden, RC 2333 ZA Netherlands Details
GSK Investigational Site Limburg 6229HX Netherlands Details
GSK Investigational Site Zwolle 8025 AB Netherlands Details
GSK Investigational Site Lodz 93-513 Poland Details
GSK Investigational Site Raciborz 47-400 Poland Details
GSK Investigational Site Coimbra 3000-075 Portugal Details
GSK Investigational Site Lisbon 1400-038 Portugal Details
GSK Investigational Site Porto 4200-072 Portugal Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Burgos 09005 Spain Details
GSK Investigational Site Cáceres 10003 Spain Details
GSK Investigational Site L'Hospitalet de Llobregat 8907 Spain Details
GSK Investigational Site Lerida 25198 Spain Details
GSK Investigational Site Lugo 27003 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Pamplona 31008 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Valencia 46015 Spain Details
GSK Investigational Site Vigo 36312 Spain Details
GSK Investigational Site Southampton Hampshire SO16 6YD United Kingdom Details
GSK Investigational Site Northwood Middlesex HA6 2RN United Kingdom Details
GSK Investigational Site Headington, Oxford Oxfordshire OX3 7LJ United Kingdom Details
GSK Investigational Site Sutton Surrey SM2 5PT United Kingdom Details
GSK Investigational Site Bebington, Wirral CH63 4JY United Kingdom Details
GSK Investigational Site Belfast BT9 7AB United Kingdom Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site Glasgow G11 6NT United Kingdom Details
GSK Investigational Site London NW1 2PG United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site London SW3 6JJ United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
GSK Investigational Site Whitchurch, Cardiff CF14 2TL United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field